App aims to boost allergy treatment completion rates
NCT ID NCT07419230
First seen Feb 27, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study tests whether a mobile app can help people with allergic rhinitis stay on their allergy immunotherapy (allergy shots or drops) for the full 3 years. Many people stop treatment early, reducing its effectiveness. The app will provide reminders and education to improve adherence. 880 participants will be randomly assigned to use the app or receive standard care, and researchers will compare how many complete the 3-year treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Infantil Universitario Niño Jesús. Avenida de Menéndez Pelayo, número 65
RECRUITINGMadrid, Madrid, 28010, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.